GlassScriptPhysician profile
Leela Raju
NPI 1972705069
$19,271.08
in general payments reported to CMS, 2019-2025
24 companies · $2,291 in 2025
The $2,291 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,369 · 2020: $191 · 2021: $1,126 · 2022: $1,767 · 2023: $3,504 · 2024: $4,023 · 2025: $2,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,900 · Food and Beverage: $2,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,900.00 |
| Food and Beverage | $2,917.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $6,244.75 | 2019-2025 | Visumax, Cirrus Hd-Oct, Quatera 700 |
| Johnson & Johnson Surgical Vision, INC. | $2,930.87 | 2019-2024 | Intralase Fs Femtosec Laser, Tecnis Simplicity, Ifs Advanced Femtosec Laser |
| Allergan, INC. | $2,030.23 | 2019 | |
| Ptc Therapeutics, INC. | $2,025.15 | 2019 | |
| Alcon Vision LLC | $2,018.53 | 2019-2025 | Clareon, Ngenuity, Hydrus Microstent |
| New World Medical,INC. | $812.98 | 2022 | |
| Lensar, INC. | $700.00 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $386.83 | 2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $386.44 | 2019-2021 | |
| Dompe US, INC. | $327.90 | 2022-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $314.52 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Ocular Therapeutix, INC. | $226.40 | 2019-2025 | Dextenza |
| Carl Zeiss Meditec USA, INC. | $210.46 | 2023 | Iolmaster 700, Quatera 700 |
| Glaukos Corporation | $209.71 | 2024-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa |
| Ani Pharmaceuticals, INC. | $87.76 | 2025 | Purified Cortrophin Gel, Yutiq, Iluvien |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Cataract Technology INC. | $87.60 | 2019 | |
| Biotissue Holdings INC. | $64.98 | 2022-2025 | |
| Oyster Point Pharma, INC. | $51.26 | 2022 | |
| Sun Pharmaceutical Industries INC. | $48.70 | 2022-2025 | |
| Sight Sciences, INC. | $24.90 | 2022 | |
| Thea Pharma INC. | $24.47 | 2022 | |
| Abbvie INC. | $23.83 | 2025 | |
| Rayner Intraocular Lenses Limited | $18.20 | 2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Endo Pharmaceuticals INC. | $14.61 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leela Raju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.